AD is associated with neuronal loss and progressive synaptic dysfunction, preceded by the deposition of amyloid-β (Aβ) peptide, a cleavage product of the amyloid-β protein precursor, and abnormal forms of tau protein, markers that have been used as diagnostic criteria for AD [21]. The gene discussed is MAPT; the disease is Alzheimer disease.